Investor Relations contacts
Home / Investor Relations / Investor Relations contacts
Contact Investor Relations
Andy Barnett
Head of Investor Relations
Christer Gruvris
Executive Director of Investor Relations
BioPharmaceuticals (Cardiovascular, Renal and Metabolism), Finance & Fixed Income
Philip Sparks
Director of Investor Relations
BioPharmaceuticals (Vaccines & Immune Therapies) and Sustainability
Elizabeth Walton
Director of Investor Relations
BioPharmaceuticals (Respiratory & Immunology)
Isabel Gibson
Director of Investor Relations
Oncology
Louise Pearson
Director of Investor Relations
Oncology
Andrew Christmas
Director of Investor Relations
Rare Disease and Sustainability
Lauren Swales
Director of Investor Relations
Rare Disease
Contact us on:
Shareholder Registrar Information
Ordinary Shares (Equiniti)
ADR Holders (EQ Shareowner Services)
Stockholm Nasdaq Shares (Euroclear)
TR1 notifications
-
Shareholder information
Please find relevant shareholder information and shareholder tools on this page
-
Shareholder FAQs
Answers to frequently asked shareholder questions
-
Governance
We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance
